| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Sestrin-2|Hypoxia-induced gene|SESN2|Hi95|SEST2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human SESN2 (Sestrin-2) is a molecular target commonly studied in cardiovascular research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of SESN2 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of SESN2 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
SESN2 (Sestrin-2) may also be referenced as Sestrin-2, Hypoxia-induced gene, and SESN2 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how SESN2 relates to vascular biology and endothelial function, cardiac remodeling and injury responses, thrombosis and hemostasis, and blood pressure regulation in cardiovascular research.
- Interpreting shifts in SESN2 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
SESN2 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cardiovascular studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease
IF: 6.376 Journal: Molecular Medicine Cited Date: 2022-12-15
Sestrin-2 and hypoxia-?nducible factor-1 alpha levels in major depressive disorder and its subtypes
IF: 4.415 Journal: Psychopharmacology Author: Department of Psychiatry, Aksaray Training and Research Hospital, Aksaray, Turkey Cited Date: 2023-06-16
Matrix metalloproteinase-9 and substance-P as predictors for early-stage diagnosis of acute mountain sickness
IF: 4.093 Journal: The American Journal of Emergency Medicine Cited Date: 2022-07-14
Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index
IF: 3.397 Journal: Journal of Endocrinological Investigation Cited Date: 2021-01-14
The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus
IF: 2.298 Journal: BMC Cardiovascular Disorders Cited Date: 2022-07-08
Maternal serum sestrin 2 levels in preeclampsia and their relationship with the severity of the disease
IF: 1.257 Journal: Hypertension in Pregnancy Cited Date: 2018-11-02
Serum sestrin 2 levels in patients with uterine leiomyomas
IF: 1.226 Journal: Journal of Obstetrics and Gynaecology Cited Date: 2022-11-25
Association of serum sestrin 2 and betatrophin with serum neutrophil gelatinase associated lipocalin levels in type 2 diabetic patients with diabetic nephropathy
IF: Journal: Journal of Diabetes & Metabolic Disorders Cited Date: 2020-02-06